OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502):
First half results aligned with management guidance
• Underlying revenue +3.8% year-to-year (reported revenue growing +6.2% to 904 billion yen)
Help employers find you! Check out all the jobs and post your resume.